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ABSTRACT 
 
Mycobacterium tuberculosis has become the cause for one of the most dreadful disease which the mankind has ever 
known i.e. Tuberculosis. The organism holds the ability to infect multiple organs at a time resulting in multiple 
symptomatic presentations in pathogenic condition while in non-pathogenic condition, it can lay dormant and 
remain asymptomatic. The research work presented here aimed at sequencing of Rifampicin Resistance Determining 
Region (RRDR) of the rpoB gene present in phenotypically multidrug resistant M. tuberculosis. The findings showed 
that the major point of mutations to be present within this region was at codon 516, 526, and 531. Early diagnosis 
of multidrug resistance in any pathogen has become a pre – requisite for proper treatment and efficient elimination 
of pathogenic organisms from the host with minimal toxicity. Similarly, understanding the mutation dynamics of 
target genes also help in novel drug design and discovery. 
 
Keywords: Mycobacterium tuberculosis, rifampicin, rpoB, RRDR, sequence 
INTRODUCTION 
Tuberculosis (TB) has a serious clinical significance 
as it holds the record for being a disease responsible for 
causing morbidity and mortality for the longest time. 
Nepal and the corresponding developing nations suffer 
most, from the brute nature of the disease [1]. The 
bacterium responsible, Mycobacterium tuberculosis, 
normally resides in the lungs causing pulmonary tuber-
culosis; however, it is not delimited to other organs, 
hence in such cases called as extra pulmonary tuber-
culosis [2]. The pathogen is infectious and takes aerial 
mode for transfer. The bacterium presents clinical symp-
toms based upon its location such that the pulmonary 
cases are recognized by chronic cough, chest pain, 
weight loss and others [3]. 
Among the distinguished members of Mycobacteria, 
M. tuberculosis holds a particular interest due to its 
clinical significance in causing various types of tuber-
culosis. Tuberculosis, a malady as old as human civili-
zation itself still holds an icy grip upon its victim despite 
the advances in treatment with vaccines and antibiotics 
[4]. Multidrug resistant M. tuberculosis (MDR – TB) is 
generally referred to that strain of Mycobacterium which 
has become resistant to both Rifampicin and Isoniazid. 
 
Mechanism of resistance for Rifampicin 
Resistance to rifampin arises due to mutations in 
the β subunit of RNA polymerase encoded by the gene 
rpoB [5]. This includes point mutations, deletions, and 
insertions [6]. This results in conformational changes 
that determine a low affinity for the drug and conse-
quently the development of resistance [7]. Most muta-
tions were determined to be restricted to an 81-bp core 
region and are dominated by single nucleotide changes, 
resulting in single amino acid substitutions, although in 
frame deletions and insertions also occur at lower fre-
quencies. Changes in the codons Ser531 and His526 
have been documented in more than 70% of the RIF-
resistant isolates [8]. 
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Figure 2. Agarose gel (2%) electrophoresis for PCR products 
amplified using MPB64 primers for confirmation of 
Mycobacterium samples. L1 – Ladder; L2 – L4: Sample 
No. 1 to 3 
 
Figure 3. Agarose gel (2%) electrophoresis for PCR products 
amplified using gene specific primers for RRDR region 
of rpoB. L1 – Ladder; L2 – L10: Sample No. 1 to 9. 
 
MATERIALS AND METHODS 
DNA preparation 
Twenty - four M. tuberculosis samples which were 
phenotypically determined as multiple drugs resistant by 
Drug Susceptibility Test were collected from Global 
hospital, Lalitpur, Nepal. DNA isolation from the lysate 
was performed using Accuprep DNA Purification KitTM.  
 
Confirmation of Mycobacterium by MPB64 Primer 
The purified DNA samples were confirmed to be 
that of Mycobacterium using MPB64 primers. The PCR 
was performed using the primer set MFP (5’-TCCGCT 
GCCAGTCGTCTTCC-3’) and MRP (5’-GTCCTCGC 
GAGTCTAGGCCA-3’). The PCR condition was set as 
initial denaturation at 95°C for 5 minutes followed by 
denaturation at 95°C for 45 seconds, 55°C for 45 
seconds and extension at 72°C for 30 seconds for 35 
cycles followed by final extension at 72°C for 10 minutes 
and hold at 4°C. 
Figure 3. Multiple Sequence Alignment for selected region of 
rpoB gene to display mutations in the codons 516, 526, 
and 531. The yellow highlighted nucleotides show the 
major codons that mutate while the red highlights 
within show changed bases when compared with the 
standard sequence of the strain L27989.1. 
Figure 4. Graph representing the number of isolates bearing 
mutation at particular locus 
 
Primer for sequencing 
rpoB gene specific primer was used as previously 
described by Fan et al. in 2003 [10]. The primer sequen-
ce covers the nucleotide sequence most prone for muta-
tion and primarily involves the region responsible for 
rifampicin resistance. Hence, the region is commonly 
referred to as Rifampicin Resistance Determining Re-
gion (RRDR). 
 
Sequencing 
Preliminary analysis of the sequence obtained was 
done using Chromas Lite 2.1.1 followed by sequence 
alignment in the software MEGA 6.06 by Clustal W. 
The final sequence was then compared with the RNA 
polymerase β subunit (rpoB) gene of the M. tuberculosis 
(Accession No. L27989.1) sequence available at Euro-
pean Nucleotide Archive (European Molecular Biology  
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Laboratory – European Bioinformatics Institute). 
 
RESULTS AND DISCUSSION 
Confirmation of M. tuberculosis by PCR 
The samples obtained were confirmed as that of M. 
tuberculosis by performing PCR with MPB64 primers. 
The confirmation was done as evident from presence of 
PCR products comparative to the band of approximately 
240 bp visualized under UV as shown in Figure 1. Out 
of 24 samples subjected to PCR, 19 samples showed pos-
itive results. Although all 24 samples were identified as 
phenotypic MDR TB, the absence of bands in 5 samples 
could be due to loss of DNA during purification step 
resulting in false negative results. This is though hard to 
be determined as many samples despite of lack- 
ing visible band in the gel gives positive result during 
the PCR amplification. So, the next probable reason 
would be the degradation of DNA during storage caus-
ing loss of amplification. This could be due to improper 
storage condition. In conclusion, out of 24 samples gath-
ered for this study, only 19 samples could be utilized for 
further down streaming processes. 
 
Sequence analysis 
A 537 bp region of DNA encompassing the RRDR 
of rpoB gene of M. tuberculosis was amplified using a 
gene specific primer which was subsequently utilized for 
sequencing (Figure 2). Analysis of the data obtained 
 
 
 
 
 
 
 
 
 
Figure 5.  Schematic diagram depicting the type and number of particular mutation as well as percentage of mutation occurring at co-
dons 516, 526, and 531 in different samples when compared to standard sequence of the strain L27989.1.  [9] 
 
Table 1. Table showing the isolates with mutation in the specific codons as validated by the sequencing. The highlighted codons rep-
resent the mutation in the codons of the sample when compared with the standard sequence of the strain L27989.1. 
Sample No. 
L27989.1 516 
Codon/AA 
Sequenced 516 
Codon/AA 
L27989.1 526 
Codon/AA 
Sequenced 526 
Codon/AA 
L27989.1 531 
Codon/AA 
Sequenced 531 
Codon/AA 
06r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
07r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
10r GAC/ Asp GAC/ Asp CAC/His GAC/Asp TCG/Ser TCG/Ser 
11r GAC/ Asp GAC/ Asp CAC/His GAC/Asp TCG/Ser TCG/Ser 
12r GAC/ Asp TAC/Tyr CAC/His CAC/His TCG/Ser TCG/Ser 
14r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
16r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TCG/Ser 
21r GAC/ Asp GTC/Val CAC/His CAC/His TCG/Ser TCG/Ser 
24r GAC/ Asp TTC/Phe CAC/His CAC/His TCG/Ser TCG/Ser 
26r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
29r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
31r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
32r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
35r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TGG/Trp 
40r GAC/ Asp GAC/ Asp CAC/His GGC/Gly TCG/Ser TCG/Ser 
43r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
45r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
46r GAC/ Asp GAC/ Asp CAC/His CAC/His TCG/Ser TTG/Leu 
49r GAC/ Asp GAC/ Asp CAC/His CGC/Arg TCG/Ser TCG/Ser 
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showed at least one mutation within the region. The 
results obtained were comparable to that done by Fan et 
al., whereby the authors observed that among the 
samples they procured, mutation was highly probable in 
the codon 531 [10]. 
In our study, mutations could be perceived only in 
the codons 516, 526 and 531 with highest percentage of 
mutation being observed at codon 531 (63.15%) fol-
lowed by codon number 526 (21.05%) and 516 (15.78%) 
(Figure 3, 4, and 5). All of the mutations witnessed in 
this study come within the RRDR of the rpoB gene as 
has been observed in several of the studies previously 
done [11, 12]. 
The RRDR is considered to be a hotspot region 
bearing several mutations responsible for imparting re-
sistance to Mycobacterium against the first line of drug, 
Rifampicin. Although all the samples showed mutation 
in the region being analysed, the resistance could not be 
solely attributed to the analysed region only and there 
might be mutations on the other sites as well. The ana-
lysis of full length gene of rpoB was not possible for our 
study; hence mutations might be present outside of the 
RRDR that could be contributing to varying degree of 
resistance against rifampicin. Further analysis of multi-
drug resistance M. tuberculosis needs to be carried to 
establish a correlation between the codon of mutation 
and the degree of resistance. 
 
CONCLUSION 
Sequence analysis of 19 samples showed mutation 
at three codons namely 516, 526, and 531. The mutation 
thus occurring possibly imparts bacterium with the 
ability to be resistant to the drug, rifampicin. Hence, for 
the timely diagnosis of the multidrug resistant 
Mycobacterium as well as improved prognosis for the 
patient, it is imperative to detect such cases at an early 
stage through accurate methods like sequencing. 
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